BresMed welcomes Jonathan Kowalski, PharmD, MS as a Chief Practice Officer and Head of BresMed US
Dr. Jonathan Kowalski has joined the BresMed Board as Chief Practice Officer (CPO) Global Pipeline Services, and EVP, Head of BresMed US.
In this role Jonathan will be responsible for continuing to expand BresMed’s presence and scope of services in the US to help clients succeed in early pipeline value strategy and evidence planning, payer & HTA launch excellence, and post-approval product differentiation. Building on BresMed’s global capabilities in early phase and pre-HTA evidence generation strategies, he will also importantly lead the new Global Pipeline Services (GPS) practice.
Jonathan joins BresMed from Allergan where he held a number of U.S. and global leadership positions over the last 20 years including VP and Head, US Health Outcomes and Value, and VP, U.S. HEOR and Global HEOR Initiatives.
Nic Brereton, BresMed CEO, commented “I am delighted to bring on board someone of Jonathan’s calibre to continue to expand our service offerings for our US based clients. Building a deep understanding of our client’s needs is fundamental to all of our consultancy services. I am confident that under Jonathan’s leadership our client focus and breadth of service will continue to grow.”
Jonathan also commented “Having been a BresMed client for over 10 years I have first-hand experience of BresMed’s world-class technical capabilities, trusted strategic insight, and client-first culture. It is an exciting time to join the passionate and highly talented BresMed team. I look forward to serving our clients with robust and highly effective solutions to meet their value planning, evidence generation, and value communication needs.”
For further information about BresMed, please visit www.bresmed.com or contact Nathaly Turner, BresMed Communications on +44 (0)114 309 4372